Characteristic | Total (n = 279) | Culture-positive (n = 170) | Culture-negative (n = 109) | p-value |
---|---|---|---|---|
Female gender, n (%) | 166 (60) | 98 (58) | 68 (62) | 0.46 |
Age, median (IQR) | 34 (27–40) | 33 (27–40) | 34 (28–40) | 0.88 |
Education beyond primary level, n (%) | 97 (35) | 61 (36) | 36 (33) | 0.70 |
CD4 count, median (IQR) (n = 274) | 49 (15–169) | 33 (12–115) | 101 (31–219) | < 0.0001 |
Antiretroviral use on admission, n (%) | 42 (15) | 24 (14) | 18 (17) | 0.37 |
Mortality, n (%) | Â | Â | Â | Â |
   In hospital (n = 279) | 23 (8) | 13 (8) | 10 (9) | 0.66 |
   Two-month (n = 241) | 65 (27) | 43 (30) | 22 (23) | 0.30 |
Clinical presentation, n (%) | Â | Â | Â | Â |
   Fever/chills/sweats | 262 (94) | 158 (93) | 104 (95) | 0.45 |
   Weight loss | 265 (95) | 167 (98) | 98 (90) | 0.003 |
   Hemoptysis | 68 (28) | 31 (21) | 37 (40) | 0.001 |